Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Heidi L. Erickson"'
1
Akademický článek
Case Report of a Fatal Antifreeze Ingestion with a Record High Level and Impressive Renal Crystal Deposition
Autor: Heidi L. Erickson
Publikováno v: Case Reports in Critical Care, Vol 2016 (2016)
Ethylene glycol, methanol, and diethylene glycol are readily available in many household and commercially available products. While these alcohols are relatively nontoxic themselves, their acidic metabolites are toxic and can result in significant mo
Externí odkaz: https://doaj.org/article/814e5636e4974fa7b5d3d5ea1e7e4298
Zobrazit plný text záznamu
2
Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022
Autor: Diya, Surie, Levi, Bonnell, Katherine, Adams, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H Keipp, Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Tresa, McNeal, Shekhar, Ghamande, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Anne P, Frosch, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Akram, Khan, William S, Bender, Abhijit, Duggal, Jennifer G, Wilson, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Nathan I, Shapiro, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Kimberly W, Hart, Sydney A, Swan, Yuwei, Zhu, Jennifer, DeCuir, Mark W, Tenforde, Manish M, Patel, Meredith L, McMorrow, Wesley H, Self, Carleigh, Samuels
Publikováno v: MMWR. Morbidity and Mortality Weekly Report. 71:1327-1334
The SARS-CoV-2 Omicron variant (B.1.1.529 or BA.1) became predominant in the United States by late December 2021 (1). BA.1 has since been replaced by emerging lineages BA.2 (including BA.2.12.1) in March 2022, followed by BA.4 and BA.5, which have ac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198a0fb85e6ad0bdec844161784e9cab
https://doi.org/10.15585/mmwr.mm7142a3
Zobrazit plný text záznamu
3
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States
Autor: Nathaniel M, Lewis, Wesley H, Self, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H, Keipp Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Shekhar A, Ghamande, Tresa A, McNeal, Nathan I, Shapiro, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Matthew E, Prekker, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Arnold S, Monto, Akram, Khan, Laurence W, Busse, Caitlin C Ten, Lohuis, Abhijit, Duggal, Jennifer G, Wilson, Alexandra June, Gordon, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Hilary M, Babcock, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, Jillian P, Rhoads, Ian D, Jones, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Christopher J, Lindsell, Kimberly W, Hart, Yuwei, Zhu, Katherine, Adams, Manish M, Patel, Mark W, Tenforde
Publikováno v: Clinical Infectious Diseases. 75:S159-S166
Background . Adults in the United States (US) began receiving the adenovirus vector coronavirus disease 2019 (COVID-19) vaccine, Ad26.COV2.S (Johnson & Johnson [Janssen]), in February 2021. We evaluated Ad26.COV2.S vaccine effectiveness (VE) against
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4efe6f52aace78e5793a53d83a0ad8
https://doi.org/10.1093/cid/ciac439
Zobrazit plný text záznamu
4
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
Autor: Anne Zepeski, Catherine L. Hough, Wesley H. Self, Ian Jones, Amira Mohamed, Tresa McNeal, Samuel M. Brown, Shekhar Ghamande, Jennifer G. Wilson, Alexandra June Gordon, Eric A. Naioti, Manjusha Gaglani, Jay S. Steingrub, Steven Y. Chang, Natalie J. Thornburg, Yuwei Zhu, Adrienne Baughman, Mark W Tenforde, Matthew E. Prekker, Christopher J. Lindsell, William B. Stubblefield, Arnold S. Monto, Nida Qadir, James D. Chappell, Nicholas M. Mohr, Carolina Rivas, Sandra N. Lester, Abhijit Duggal, Ithan D. Peltan, Kevin W Gibbs, Jillian P. Rhoads, Jennifer R. Verani, Miwako Kobayashi, Hilary M. Babcock, Manish M. Patel, Arber Shehu, Emily T. Martin, Natasha B. Halasa, Laurence W. Busse, Megan M. Stump, Jennie H. Kwon, David J. Douin, Daniel J. Henning, Matthew C. Exline, Kelsey N Womack, Michelle N. Gong, Todd W. Rice, Samantha M. Olson, H. Keipp Talbot, Adam S. Lauring, Jonathan D Casey, Adit A. Ginde, Kimberly W. Hart, Heidi L Erickson, D. Clark Files, David N. Hager, Carlos G. Grijalva, Lisa Mills, Christopher Mallow, Akram Khan, Caitlin C Ten Lohuis
Publikováno v: Morbidity and Mortality Weekly Report
Three COVID-19 vaccines are authorized or approved for use among adults in the United States (1,2). Two 2-dose mRNA vaccines, mRNA-1273 from Moderna and BNT162b2 from Pfizer-BioNTech, received Emergency Use Authorization (EUA) by the Food and Drug Ad
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3695ec34b8521f85c10fe2b51a1b6080
https://doi.org/10.15585/mmwr.mm7038e1
Zobrazit plný text záznamu
6
Bedside veno‐venous ECMO cannulation: A pertinent strategy during the COVID‐19 pandemic
Autor: Heidi L Erickson, Louis P. Kohl, Matthew E. Prekker, Domenico Calcaterra, Beth Heather
Publikováno v: Journal of Cardiac Surgery
Background Patient selection and cannulation arguably represent the key steps for the successful implementation of extracorporeal membrane oxygenation (ECMO) support. Cannulation is traditionally performed in the operating room or the catheterization
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd8e756ab96c9cc827be5c5e8a9cb8d
http://europepmc.org/articles/PMC7323207
Zobrazit plný text záznamu
9
Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States
Autor: Mark W, Tenforde, Wesley H, Self, Yuwei, Zhu, Eric A, Naioti, Manjusha, Gaglani, Adit A, Ginde, Kelly, Jensen, H Keipp, Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Tresa, McNeal, Shekhar, Ghamande, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Matthew E, Prekker, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Arnold S, Monto, Akram, Khan, Catherine L, Hough, Laurence W, Busse, Caitlin, Ten Lohuis, Abhijit, Duggal, Jennifer G, Wilson, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Hilary M, Babcock, Jennie H, Kwon, Matthew C, Exline, Mena M, Botros, Adam S, Lauring, Nathan I, Shapiro, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, Ian D, Jones, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Jillian P, Rhoads, Christopher J, Lindsell, Kimberly W, Hart, Caitlin, Turbyfill, Samantha, Olson, Nancy, Murray, Katherine, Adams, Manish M, Patel
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
COVID-19 mRNA vaccines were authorized in the United States in December 2020. Although vaccine effectiveness (VE) against mild infection declines markedly after several months, limited understanding exists on the long-term durability of protection ag
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::73a2476fa89115f505071a8bb09e694d
https://pubmed.ncbi.nlm.nih.gov/35580849
Zobrazit plný text záznamu
10
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Autor: Amira Mohamed, Catherine L. Hough, Manjusha Gaglani, Nathan I. Shapiro, Samantha M. Olson, Abhijit Duggal, Arber Shehu, Manish M. Patel, Kimberly W. Hart, Laurence W. Busse, William B Stubblefield, Emily T. Martin, Ithan D. Peltan, Caitlin C Ten Lohuis, Kevin W Gibbs, Jillian P. Rhoads, Mark W Tenforde, Tresa McNeal, Miwako Kobayashi, Jennifer G. Wilson, Christopher J. Lindsell, Alexandra June Gordon, Kelsey N Womack, Steven Y. Chang, Jay S. Steingrub, Samuel M. Brown, Anne Zepeski, Carolina Rivas, Daniel J. Henning, Jennie H. Kwon, Christopher Mallow, Michelle N. Gong, Shekhar Ghamande, Todd W. Rice, Adrienne Baughman, Influenza, Jennifer R. Verani, Arnold S. Monto, Nida Qadir, James D. Chappell, Akram Khan, Nicholas M. Mohr, Natasha B. Halasa, H. Keipp Talbot, Hilary M. Babcock, David J. Douin, Yuwei Zhu, Carlos G. Grijalva, Matthew E. Prekker, Wesley H. Self, D. Clark Files, David N. Hager, Katherine Adams, Adam S. Lauring, Ian Jones, Matthew C. Exline, Heidi L Erickson, Jonathan D Casey, Adit A. Ginde
Publikováno v: JAMA
IMPORTANCE: A comprehensive understanding of the benefits of COVID-19 vaccination requires consideration of disease attenuation, determined as whether people who develop COVID-19 despite vaccination have lower disease severity than unvaccinated peopl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0de4b15d4eaf88d751fd07e65278925
https://europepmc.org/articles/PMC8569602/
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje